Celtura: Pilot trial data

Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Product: Celtura Business: Infectious Molecular target: Not applicable Description: MF59-adjuvanted cell culture-based swine influenza A (H1N1) va...